Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results
Select data models

Selected data models

You must log in to select data models for download or further analysis.

1 Search results.

Modified Hoehn And Yahr Parkinson’s Disease Staging Screening Ropinirole Parkinson Disease 101468/165 - Modified Hoehn And Yahr Parkinson’s Disease Staging Screening

- 10/16/17 - 1 form, 1 itemgroup, 4 items, 1 language

Itemgroup: Modified Hoehn and Yahr Staging

Study Part: Modified Hoehn And Yahr Parkinson’s Disease Staging Screening. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial

Keywords

Table of contents

Selected data models

Modified Hoehn And Yahr Parkinson’s Disease Staging Screening Ropinirole Parkinson Disease 101468/165 - Modified Hoehn And Yahr Parkinson’s Disease Staging Screening

Keywords

Table of contents

Selected data models

Modified Hoehn And Yahr Parkinson’s Disease Staging Screening Ropinirole Parkinson Disease 101468/165 - Modified Hoehn And Yahr Parkinson’s Disease Staging Screening

Contact

Help